Qura, Inc.

qura™ is a preclinical medical device and data company that is developing novel implantable active wireless sensors enabling better and more cost-effective management of cardiovascular disease and related comorbid conditions. qura’s devices feature extreme miniaturization of components and a previously unachieved ability continually to acquire and autonomously transmit key patient data measuring multiple physiologic parameters (including pressures, oxygen saturation and temperature). firmly established proof of concept with confirmatory bench and animal studies. working at the intersection of advanced medical devices and big data, qura will enable a new frontier in value-based patient care, disease management, and telehealth services. qura’s initial target market is cardiovascular disease where pressure guided therapy is warranted. this initial application represents a $10 billion opportunity for remote monitoring for arterial hypertension and advanced congestive heart failure alone,